Indivior Pharmaceuticals, Inc. (INDV)
NASDAQ · Healthcare
Indivior Pharmaceuticals, Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 1.24B | 1.19B | 1.09B | 901.0M |
| Gross Profit | 994.0M | 957.0M | 919.0M | 749.0M |
| Profitability | ||||
| Operating Income | 262.0M | 38.0M | -152.0M | -81.0M |
| EBITDA | 272.0M | 54.0M | -137.0M | -65.0M |
| Net Income | 210.0M | 7.0M | -126.0M | -44.0M |
| Per Share Data | ||||
| EPS (diluted) | $1.64 | $0.05 | $-0.92 | $-0.32 |
| Shares Outstanding (dil.) | 128M | 133M | 137M | 139M |
Indivior Pharmaceuticals, Inc. Income Statement — FAQ
Indivior Pharmaceuticals, Inc. (INDV) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INDV's income statement history?
The chart and table above show Indivior Pharmaceuticals, Inc.'s income statement by year and by quarter, including the growth rate.